Results 191 to 200 of about 101,514 (215)

Molecular mechanisms and potential targeting strategies of ubiquitin‑proteasome system‑mediated PD‑1/PD‑L1 ubiquitination in tumor immune suppression (Review). [PDF]

Oncol Rep
Gu LH, Guo A, Ding YY, Wang XJ, Zhang HX, Duan WL, Zhang BG.   +6 more
europepmc   +1 more source

Ubiquitin-proteasome system: a potential participant and therapeutic target in antiphospholipid syndrome. [PDF]

Front Immunol
Wang H, Tan Y, Liu Q, Yang S, Cui L.
europepmc   +1 more source

Identification and mechanistic insights of ubiquitin-proteasome system and pyroptosis-related biomarkers in type 2 diabetes mellitus. [PDF]

World J Diabetes
Yuan XJ, Zhang ZC, Li J, Ye SD, Zhou W.
europepmc   +1 more source

Commentary: The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy. [PDF]

Front Immunol
Zhang L, Jia L, Wang L, Yuan W, Shi X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
, Jill Barnholtz-Sloan, Carol Kruchko
exaly  

Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer

Ca-A Cancer Journal for Clinicians, 2023
Elliot Asare
exaly  

Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer

Ca-A Cancer Journal for Clinicians, 2023
Elliot Asare
exaly  

An Evidence-based Staging System for Cutaneous Melanoma

Ca-A Cancer Journal for Clinicians, 2004
John Thompson, John F Thompson
exaly  

Primary central nervous system tumors: advances in knowledge and treatment

Ca-A Cancer Journal for Clinicians, 1998
Mitchel Berger, M D Prados
exaly